Chemoinformaics analysis of 1,6,10-DODECATRIEN-3-OL
| Molecular Weight | 180.291 | nRot | 7 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
| Exact Molecular Weight | 180.151 | nRing | 0 |
| Solubility: LogS | -2.436 | nHRing | 0 |
| Solubility: LogP | 3.432 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.1779 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.471 |
| Synth | 3.649 |
| Natural Product Likeliness | 2.579 |
| NR-PPAR-gamma | 0.165 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.091 |
| HIA | 0.009 |
| CACO-2 | -4.328 |
| MDCK | 0.0000361 |
| BBB | 0.945 |
| PPB | 0.829862 |
| VDSS | 1.254 |
| FU | 0.166175 |
| CYP1A2-inh | 0.385 |
| CYP1A2-sub | 0.401 |
| CYP2c19-inh | 0.105 |
| CYP2c19-sub | 0.525 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.668 |
| CYP3a4-inh | 0.207 |
| CYP3a4-sub | 0.198 |
| CL | 9.48 |
| T12 | 0.563 |
| hERG | 0.002 |
| Ames | 0.019 |
| ROA | 0.035 |
| SkinSen | 0.821 |
| Carcinogencity | 0.068 |
| EI | 0.979 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.669124 |